ArticleMolecular therapy : the journal of the American Society of Gene Therapy2026

Podocyte-directed VEGFC gene therapy prevents increased glomerular permeability and glycocalyx damage in experimental type 1 diabetes.

Aldara Martin Alonso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.